CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Market share analysis, 2020
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in incidences of musculoskeletal conditions
3.4.1.2.Technological advancements in medical devices leading to a shift from autograft to allograft
3.4.1.3.Development of biocompatible synthetic bone grafts
3.4.1.4.Obesity and diabetes to increase the risk of degenerative joint diseases
3.4.2.Restraints
3.4.2.1.High cost of surgeries
3.4.2.2.Ethical issues related with bone grafting procedures
3.4.3.Opportunities
3.4.3.1.Emerging markets to offer lucrative growth opportunities
3.5.Government Regulations
3.5.1.FDA
3.5.2.Health Canada
3.5.3.CE Mark
3.5.4.Ministry of Health, Labor and Welfare (MHLW)
3.5.5.Therapeutic Goods Administration (TGA)
3.6.Reimbursement Scenario
3.6.1.U.S.
3.6.2.Europe
3.6.3.Asia-Pacific
3.6.4.LAMEA
3.7.COVID-19 Impact analysis on the market

CHAPTER 4:BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Allografts
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.2.5.Machined Allografts
4.2.5.1.Market size and forecast
4.2.6.Demineralized Bone Matrix (DBM)
4.2.6.1.Market size and forecast
4.3.Bone Graft Substitutes
4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.3.5.Bone Morphogenic Proteins (BMP)
4.3.5.1.Market size and forecast
4.3.6.Synthetic Bone Grafts
4.3.6.1.Market size and forecast
4.4.Cell-based Matrices (CBM)
4.4.1.Key market trends, growth factors and opportunities
4.4.1.1.Cell-based matrices-major products
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Spinal Fusion
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Trauma
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Craniomaxillofacial Surgery
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Joint Reconstruction
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
5.6.Dental Bone Grafting
5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:BONE GRAFTS & SUBSTITUTES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. Bone grafts & substitutes market by type
6.2.2.1.2.U.S. Bone grafts & substitutes market by application
6.2.2.2.Canada
6.2.2.2.1.Canada Bone grafts & substitutes market by type
6.2.2.2.2.Canada Bone grafts & substitutes market by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico Bone grafts & substitutes market by type
6.2.2.3.2.Mexico Bone grafts & substitutes market by application
6.2.3.Market size and forecast, by type
6.2.4.Market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany Bone grafts & substitutes market by type
6.3.2.1.2.Germany Bone grafts & substitutes market by application
6.3.2.2.France
6.3.2.2.1.France Bone grafts & substitutes market by type
6.3.2.2.2.France Bone grafts & substitutes market by application
6.3.2.3.Italy
6.3.2.3.1.Italy Bone grafts & substitutes market by type
6.3.2.3.2.Italy Bone grafts & substitutes market by application
6.3.2.4.Spain
6.3.2.4.1.Spain Bone grafts & substitutes market by type
6.3.2.4.2.Spain Bone grafts & substitutes market by application
6.3.2.5.UK
6.3.2.5.1.UK Bone grafts & substitutes market by type
6.3.2.5.2.UK Bone grafts & substitutes market by application
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe Bone grafts & substitutes market by type
6.3.2.6.2.Rest of Europe Bone grafts & substitutes market by application
6.3.3.Market size and forecast, by type
6.3.4.Market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan
6.4.2.1.1.Japan Bone grafts & substitutes market, by type
6.4.2.1.2.Japan Bone grafts & substitutes market, by application
6.4.2.2.China
6.4.2.2.1.China Bone grafts & substitutes market, by type
6.4.2.2.2.China Bone grafts & substitutes market, by application
6.4.2.3.India
6.4.2.3.1.India Bone grafts & substitutes market, by type
6.4.2.3.2.India Bone grafts & substitutes market, by application
6.4.2.4.Australia
6.4.2.4.1.Australia Bone grafts & substitutes market, by type
6.4.2.4.2.Australia Bone grafts & substitutes market, by application
6.4.2.5.South Korea
6.4.2.5.1.South Korea Bone grafts & substitutes market, by type
6.4.2.5.2.South Korea Bone grafts & substitutes market, by application
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific Bone grafts & substitutes market, by type
6.4.2.6.2.Rest of Asia-Pacific Bone grafts & substitutes market, by application
6.4.3.Asia-Pacific Bone grafts &substitutes market, by type
6.4.4.Asia-Pacific Bone grafts & substitutes market, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil bone grafts & substitutes market, by type
6.5.2.1.2.Brazil bone grafts & substitutes market, by application
6.5.2.2.Israel
6.5.2.2.1.Israel bone grafts & substitutes market, by type
6.5.2.2.2.Israel bone grafts & substitutes market, by application
6.5.2.3.Saudi Arabia
6.5.2.3.1.Saudi Arabia bone grafts & substitutes market, by type
6.5.2.3.2.Saudi Arabia bone grafts & substitutes market, by application
6.5.2.4.South Africa
6.5.2.4.1.South Africa bone grafts & substitutes market, by type
6.5.2.4.2.South Africa bone grafts & substitutes market, by application
6.5.2.5.Rest of LAMEA
6.5.2.5.1.Rest of LAMEA bone grafts & substitutes market, by type
6.5.2.5.2.Rest of LAMEA bone grafts & substitutes market, by application
6.5.3.Market size and forecast, by type
6.5.4.Market size and forecast, by application

CHAPTER 7:COMPANY PROFILES
7.1.ARTHREX, INC.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product Portfolio
7.2.BAXTER INTERNATIONAL INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product Portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.INTEGRA LIFESCIENCES HOLDINGS CORPORATION
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.4.JOHNSON & JOHNSON (DEPUY SYNTHES)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product Portfolio
7.4.5.Business performance
7.5.MEDTRONIC PLC
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MUSCULOSKELETAL TRANSPLANT FOUNDATION
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product Portfolio
7.7.NUVASIVE, INC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product Portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments
7.8.STRYKER CORPORATION
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.XTANT MEDICAL HOLDINGS, INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product Portfolio
7.9.5.Business performance
7.10.ZIMMER BIOMET HOLDINGS, INC.,
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance

List of Tables

TABLE 01.BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020 2028 ($MILLION)
TABLE 02.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFT, BY TYPE 2020-2028 ($MILLION)
TABLE 03.BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY REGION 2020-2028 ($MILLION)
TABLE 04.BONE GRAFTS & SUBSTITUTES MARKET FOR MACHINED ALLOGRAFTS, BY REGION , 2020-2028 ($MILLION)
TABLE 05.BONE GRAFTS & SUBSTITUTES MARKET FOR DEMINERALIZED BONE MATRIX, BY REGION, 2020-2028 ($MILLION)
TABLE 06.BONE GRAFTS SUBSTITUTES MARKET, BY TYPE ($MILLION), 2020-2028
TABLE 07.BONE GRAFTS SUBSTITUTES MARKET, BY REGION ($MILLION), 2020-2028
TABLE 08.BONE GRAFTS & SUBSTITUTES MARKET FOR BONE MORPHOGENETIC PROTEIN, BY REGION, 2020-2028 ($MILLION)
TABLE 09.BONE GRAFTS & SUBSTITUTES MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020 & 2028 ($MILLION)
TABLE 10.CELL-BASED MATRICES- MAJOR PRODUCTS AND STRATEGIES
TABLE 11.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY REGION, 2020 & 2028 ($MILLION)
TABLE 12.BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 ($MILLION),
TABLE 13.BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020 & 2028 ($MILLION)
TABLE 14.BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY REGION, 2020 & 2028 ($MILLION)
TABLE 15.BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY REGION 2020 & 2028 ($MILLION)
TABLE 16.BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY REGION 2020 & 2028 ($MILLION)
TABLE 17.BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY REGION, 2020 & 2028 ($MILLION)
TABLE 18.BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY REGION, 2020 & 2028 ($MILLION)
TABLE 19.BONE GRAFTS & SUBSTITUTES MARKET, BY REGION, 2020 - 2028 ($MILLION)
TABLE 20.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 21.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 22.U.S. BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 23.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 24.CANADA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 25.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 26.MEXICO BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 27.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 28.NORTH AMERICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021-2028 ($MILLION)
TABLE 29.EUROPE BONE GRAFTS & SUBSTITUTES, BY COUNTRY 2020-2028 ($MILLION)
TABLE 30.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 31.GERMANY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 32.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 33.FRANCE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 34.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 35.ITALY BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 36.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 37.SPAIN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 38.UK BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 39.UK BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 40.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 41.REST OF EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 42.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 43.EUROPE BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
TABLE 44.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 45.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 46.JAPAN BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 47.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 48.CHINA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 49.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 50.INDIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 51.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 52.AUSTRALIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 53.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 54.SOUTH KOREA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 56.REST OF ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 57.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 58.ASIA-PACIFIC BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION, 2020-2028 ($MILLION)
TABLE 59.LAMEA BONE GRAFTS & SUBSTITUTES, BY COUNTRY ($MILLION), 2020-2028
TABLE 60.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 61.BRAZIL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
TABLE 62.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 63.ISRAEL BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2021-2028 ($MILLION)
TABLE 64.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 65.SAUDI ARABIA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
TABLE 66.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 67.SOUTH AFRICA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
TABLE 68.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 69.REST OF LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
TABLE 70.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY TYPE 2020-2028 ($MILLION)
TABLE 71.LAMEA BONE GRAFTS & SUBSTITUTES MARKET, BY APPLICATION 2020-2028 ($MILLION)
TABLE 72.ARTHREX: COMPANY SNAPSHOT
TABLE 73.ARTHREX: PRODUCT CATEGORIES
TABLE 74.ARTHREX: PRODUCT PORTFOLIO
TABLE 75.BAXTER: COMPANY SNAPSHOT
TABLE 76.BAXTER: BUSINESS UNITS
TABLE 77.BAXTER: PRODUCT PORTFOLIO
TABLE 78.BAXTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79.INTEGRA: COMPANY SNAPSHOT
TABLE 80.INTEGRA: OPERATING SEGMENTS
TABLE 81.INTEGRA: PRODUCT PORTFOLIO
TABLE 82.J&J: COMPANY SNAPSHOT
TABLE 83.J&J: OPERATING SEGMENTS
TABLE 84.J&J: PRODUCT PORTFOLIO
TABLE 85.MEDTRONIC: COMPANY SNAPSHOT
TABLE 86.MEDTRONIC: OPERATING SEGMENTS
TABLE 87.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88.MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89.MTF BIOLOGICS: COMPANY SNAPSHOT
TABLE 90.MTF BIOLOGICS: PRODUCT OFFERINGS
TABLE 91.MTF BIOLOGICS: PRODUCT PORTFOLIO
TABLE 92.NUVASIVE: COMPANY SNAPSHOT
TABLE 93.NUVASIVE: PRODUCT LINE
TABLE 94.NUVASIVE: PRODUCT PORTFOLIO
TABLE 95.NUVASIVE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96.STRYKER: COMPANY SNAPSHOT
TABLE 97.STRYKER: OPERATING SEGMENTS
TABLE 98.STRYKER: PRODUCT PORTFOLIO
TABLE 99.STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100.XTNT: COMPANY SNAPSHOT
TABLE 101.XTNT: OPERATING SEGMENTS
TABLE 102.XTNT: PRODUCT PORTFOLIO
TABLE 103.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 104.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 105.ZIMMER BIOMET: PRODUCT PORTFOLIO

List of Figures

FIGURE 01.SEGMENTATION: BONE GRAFTS & SUBSTITUTES MARKET
FIGURE 02.TOP INVESTMENT POCKETS: BONE GRAFTS & SUBSTITUTES MARKET
FIGURE 01.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2018-2021*
FIGURE 02.TOP WINNING STRATEGIES: BY DEVELOPMENT, 2018-2021* (%)
FIGURE 03.TOP WINNING STRATEGIES: BY COMPANY, 2018-2021* (%)
FIGURE 01.MARKET SHARE ANALYSIS: BONE GRAFTS AND SUBSTITUTES, 2020
FIGURE 02.MARKET SHARE ANALYSIS: MACHINED ALLOGRAFTS, 2020
FIGURE 03.MARKET SHARE ANALYSIS: DEMINERALISED BONE MATRIX, 2020
FIGURE 04.MARKET SHARE ANALYSIS: BONE MORPHOGENIC PROTEINS, 2020
FIGURE 05.MARKET SHARE ANALYSIS: SYNTHETIC BONE GRAFTS, 2020
FIGURE 06.MARKET SHARE ANALYSIS: CELL BASED MATRICES, 2020
FIGURE 07.MARKET DYNAMICS
FIGURE 08.BONE GRAFTS & SUBSTITUTES MARKET: BY PRODUCT TYPE
FIGURE 09.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR ALLOGRAFTS, BY COUNTRY, 2020 & 2028(%)
FIGURE 10.COMPARATIVE ANALYSIS OF BONE GRAFTS SUBSTITUTES MARKET, BY COUNTRY, 2020-2028 (%)
FIGURE 11.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CELL BASED MATRICES, BY COUNTRY, 2020 & 2028 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR SPINAL FUSION, BY COUNTRY, 2020 & 2028 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR TRAUMA, BY COUNTRY, 2020 & 2028 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR CRANIOMAXILLOFACIAL SURGERY, BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR JOINT RECONSTRUCTION, BY COUNTRY, 2020 & 2028 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF BONE GRAFTS & SUBSTITUTES MARKET FOR DENTAL BONE GRAFTING, BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.BAXTER: NET SALES, 2018-2020 ($MILLION)
FIGURE 18.BAXTER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 19.BAXTER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 20.INTEGRA: NET SALES, 2018-2020 ($MILLION)
FIGURE 21.INTEGRA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 22.INTEGRA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 23.J&J: REVENUE, 2018-2020 ($MILLION)
FIGURE 24.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.J&J: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.MEDTRONIC: NET SALES, 2018-2020 ($MILLION)
FIGURE 27.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29.NUVASIVE: NET SALES, 2018-2020 ($MILLION)
FIGURE 30.NUVASIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.NUVASIVE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32.STRYKER: NET SALES, 2018-2020 ($MILLION)
FIGURE 33.STRYKER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.STRYKER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.XTNT: NET SALES, 2018-2020 ($MILLION)
FIGURE 36.XTNT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.XTNT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.ZIMMER BIOMET: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.ZIMMER BIOMET: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.ZIMMER BIOMET: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned
Major players that operate in this market include Arthrex, Inc., Baxter International Inc., Integra LifeSciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive, Inc., Stryker Corporation, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc.